CYH

Business Context and Reporting Period

Company: Community Health Systems, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Overview: The Company is the largest non-urban provider of general hospital healthcare services in the U.S. by facility count and second largest by revenue. As of year-end 2001, it owned, leased, or operated 57 hospitals across 20 states with 5,391 licensed beds. In over 85% of its markets, it is the sole provider of general hospital services.

Key Financial Metrics

Note: EBITDA is defined as income before extraordinary items, interest, taxes, depreciation, and amortization.

Material Changes vs. Prior Period

• Revenue Growth: Net operating revenues increased 26.6% to $1.69 billion, driven by acquisitions ($218.3 million contribution) and organic growth at same hospitals ($137.8 million or 10.4%).
• Profitability: Net income surged to $44.7 million from $9.6 million in 2000, primarily due to revenue growth, expense control, and a significant reduction in interest expense ($32.9 million decrease).
• Acquisitions: Acquired five hospitals in 2001 for approximately $215.1 million. Post-year-end, acquired two additional hospitals for $70 million.
• Debt Reduction: Total debt decreased by approximately $180 million. The Company raised $585.8 million in October 2001 via equity and convertible debt offerings to repay $500 million of subordinated debentures and other long-term debt.
• Same-Hospital Performance: On a same-hospital basis, EBITDA margin improved from 18.6% in 2000 to 19.1% in 2001, reflecting operational efficiencies.

Guidance, Outlook, and Risks

• Capital Expenditures: The Company expects total capital expenditures of $102 million to $110 million in 2002, including $32 million to $35 million for constructing four replacement hospitals required by purchase agreements.
• Acquisition Strategy: Plans to acquire two to four hospitals annually in non-urban markets. A definitive agreement was signed in November 2001 to acquire a hospital in New Jersey, expected to close in Q2 2002.
• Accounting Changes: Adopted SFAS No. 142 effective January 1, 2002. Goodwill is no longer amortized but tested for impairment annually. This change is expected to increase 2002 earnings by approximately $0.24 per share (after tax) by eliminating goodwill amortization expense.
• Regulatory Risks: Significant reliance on Medicare (33.5%) and Medicaid (11.3%) reimbursement. Future legislative changes or payment rate reductions could adversely affect results. The Company is subject to a Corporate Compliance Agreement with the Office of Inspector General through June 2003 following a 2000 settlement regarding coding inaccuracies.
• Legal Contingencies: Pending qui tam litigation regarding Medicare billing (dismissed at district court level, under appeal) and a potential liability regarding a nurse's illegal drug use at a Texas facility (risk deemed remote).

Investor Verification Checklist

• Reimbursement Rates: Verify the impact of potential Medicare/Medicaid payment cuts on the 45% of revenue derived from government programs.
• Debt Covenants: Review the amended credit agreement covenants regarding senior indebtedness to EBITDA ratios and fixed charge coverage.
• Goodwill Impairment: Monitor the annual goodwill impairment testing under SFAS No. 142, given that goodwill represented 89.7% of shareholders' equity at year-end 2001.
• Compliance Agreement: Confirm adherence to the Corporate Compliance Agreement terms to avoid penalties or exclusion from federal programs.
• Construction Commitments: Track the $83 million remaining obligation for replacement hospital construction through 2005.